Thielsen Capital is a seed stage financing syndicate network which brings together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science.
With a laser focus on life science tools, biotech infrastructure, and platform technologies, we work with teams to build companies at the pre-seed and seed stages. Three key points make Thielsen different.
We understand (since we have been there) that life science tools companies require incredible founder-operator "magic," have the potential for non-binary outcomes, and exist first to serve science.
With our industry experience, competency in deep tech, and thesis-driven focus, we move quickly with our diligence process -- often working with founders years or months before an investment -- so we can get back to building together.
We are creatively addressing a need for greater seed funding paired with strategic and operational guidance in life science tools and biotech infrastructure, while incentivizing our network of innovators and operators to source the best, transformative life science companies.
Our approach is to not just fund, but surround founders and operating teams with trail guides who bring decades of experience to go-to-market planning, recruitment, technology development, M+A, and business development. The syndicate network brings active and former operators close to founders, with skin in the game, to drive exceptional outcomes.
If you are ready to work with us, please reach out and send us a summary and pitch deck.